Search research articles
Contact Us
Filters
Showing results (11-20 of 205) with videos related to
Page
of 21
Sort By:
Pharmacology & Therapeutics
|
August 2, 2005
Challenges in the adoption of new pharmacotherapeutics for addiction to alcohol and other drugs
Andrew J Saxon, Dennis McCarty
JAMA Internal Medicine
|
April 4, 2018
The Role of Cannabis Legalization in the Opioid Crisis
Kevin P Hill, Andrew J Saxon
General Hospital Psychiatry
|
November 2, 2013
Marijuana not ready for prime time as an analgesic
Andrew J Saxon, Kendall W Browne
Addiction Science & Clinical Practice
|
February 3, 2022
Introduction to the Special Series: National Drug Abuse Treatment Clinical Trials Network and the Opioid Use Disorder Care Continuum-20 years of research informing practice
Andrew J Saxon, E Jennifer Edelman
Archives of General Psychiatry
|
December 8, 2010
Tobacco use data questioned in veterans study
Andrew J Saxon, Miles E McFall
Journal of Food and Drug Analysis
|
September 30, 2014
Medication-assisted therapy for opioid addiction
Betty Tai, Andrew J Saxon, Walter Ling
Journal of Addiction Medicine
|
May 26, 2016
Some Additional Considerations Regarding the American Society of Addiction Medicine National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use
Andrew J Saxon, Elinore F McCance-Katz
The American Journal of Psychiatry
|
February 2, 2019
Prazosin for Alcohol Use Disorder: Response to Kleinman and Ostacher
Tracy L Simpson, Andrew J Saxon, Murray Raskind
Harvard Review of Psychiatry
|
August 30, 2005
Genetic determinants of addiction to opioids and cocaine
Andrew J Saxon, Michael R Oreskovich, Zoran Brkanac
Journal of Clinical Psychopharmacology
|
January 18, 2006
Pharmacokinetic profile of an oral loading dose of divalproex sodium during acute alcohol withdrawal
Joseph P Reoux, Andrew J Saxon, Danny Shen
Page
of 21
Search research articles
Search
Showing results (11-20 of 205) with videos related to
Sort By:
Page
of 21
Pharmacology & Therapeutics
|
August 2, 2005
Challenges in the adoption of new pharmacotherapeutics for addiction to alcohol and other drugs
Andrew J Saxon, Dennis McCarty
JAMA Internal Medicine
|
April 4, 2018
The Role of Cannabis Legalization in the Opioid Crisis
Kevin P Hill, Andrew J Saxon
General Hospital Psychiatry
|
November 2, 2013
Marijuana not ready for prime time as an analgesic
Andrew J Saxon, Kendall W Browne
Addiction Science & Clinical Practice
|
February 3, 2022
Introduction to the Special Series: National Drug Abuse Treatment Clinical Trials Network and the Opioid Use Disorder Care Continuum-20 years of research informing practice
Andrew J Saxon, E Jennifer Edelman
Archives of General Psychiatry
|
December 8, 2010
Tobacco use data questioned in veterans study
Andrew J Saxon, Miles E McFall
Journal of Food and Drug Analysis
|
September 30, 2014
Medication-assisted therapy for opioid addiction
Betty Tai, Andrew J Saxon, Walter Ling
Journal of Addiction Medicine
|
May 26, 2016
Some Additional Considerations Regarding the American Society of Addiction Medicine National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use
Andrew J Saxon, Elinore F McCance-Katz
The American Journal of Psychiatry
|
February 2, 2019
Prazosin for Alcohol Use Disorder: Response to Kleinman and Ostacher
Tracy L Simpson, Andrew J Saxon, Murray Raskind
Harvard Review of Psychiatry
|
August 30, 2005
Genetic determinants of addiction to opioids and cocaine
Andrew J Saxon, Michael R Oreskovich, Zoran Brkanac
Journal of Clinical Psychopharmacology
|
January 18, 2006
Pharmacokinetic profile of an oral loading dose of divalproex sodium during acute alcohol withdrawal
Joseph P Reoux, Andrew J Saxon, Danny Shen
Page
of 21